Skip to main content

Books in Toxicology

Elsevier's Toxicology collection provides essential insights for researchers and scientists into mitigating the adverse effects of contaminants on organisms, covering research, analysis, risk assessment, detection, prevention, diagnosis, and treatment of toxic exposure. Including toxicity testing, environmental toxicology it offers valuable knowledge for addressing public health and safety challenges by examining the adverse effects of contaminants on human health, animals, and the environment.

    • Receptors

      • 1st Edition
      • January 26, 2016
      • J. Jacob
      • English
      • Hardback
        9 7 8 0 0 8 0 2 3 1 9 1 4
      • Paperback
        9 7 8 1 4 8 3 1 2 5 5 4 1
      • eBook
        9 7 8 1 4 8 3 1 5 7 9 6 2
      Advances in Pharmacology and Therapeutics, Volume l: Receptors contains the proceedings of the 7th International Congress of Pharmacology held in Paris, France, in 1978. The papers explore advances in the understanding of receptors, their pharmacology, and their therapeutic applications. Topics covered range from opiate receptors and their endogenous ligands to membrane receptors in eukaryotic cells. Applications of binding to pharmacological research are also discussed. This volume is comprised of 29 chapters and opens with an overview of the chemistry and biochemistry of pituitary endorphins, paying particular attention to the correlation between the analgesic potency, receptor binding properties, preferred solution conformation, and metabolic stability of natural and synthetic opioid peptides. The reader is then introduced to the biosynthesis and release of the enkephalins; opiate receptors and their endogenous ligands; denervation supersensitivity in skeletal muscle; and biochemistry and physiology of dopaminergic and beta-adrenergic receptors in mammalian central nervous system. The following chapters explore the role of guanylnucleotides in the regulation of hormonally stimulated adenylate cyclase; interactions of cholera toxin with cell membranes; problems in studying hormone receptor binding; and the mechanism of action of anti-hormones. This book will be of interest to practitioners in biosciences, pharmacology, physiology, and medicine.
    • Chemotherapy

      • 1st Edition
      • October 27, 2016
      • M. Adolphe
      • English
      • Paperback
        9 7 8 1 4 8 3 1 7 2 7 9 8
      • eBook
        9 7 8 1 4 8 3 1 8 8 6 0 7
      Advances in Pharmacology and Therapeutics, Volume 10: Chemotherapy covers the proceedings of the 7th International Congress of Pharmacology. The title presents papers that detail the advancement of pharmacological research in chemotherapy. The text first covers the chemotherapy of schistosomiasis. Next, the selection presents the trends in malaria and cancer chemotherapy, along with their pharmacological research. The text also details the use of cell cultures as tools in pharmacological investigations. The book will be of great interest to pharmacologists and oncologists.
    • The Prostaglandins

      • 1st Edition
      • January 26, 2016
      • M. F. Cuthbert
      • English
      • Paperback
        9 7 8 1 4 8 3 1 7 6 9 9 4
      • eBook
        9 7 8 1 4 8 3 1 9 2 8 0 2
      The Prostaglandins: Pharmacological and Therapeutic Advances provides a concise account of the more important theoretical developments and areas in which the prostaglandins are being introduced into clinical practice or have potential clinical application. Chapters I to IV of this book deal with the chemistry and classification, distribution and metabolism, general pharmacology, and mechanism of action. The rest of the chapters discuss the relationship of the prostaglandins to the reproductive, cardiovascular, respiratory, and gastro-intestinal systems with an emphasis on the human pharmacology and potential therapeutic applications. This text also includes the speculations and suggestions of contributors regarding the possible and further use of the prostaglandins. This publication is a good reference for biochemists and medical students concerned with the potential of prostaglandins.
    • Pharmacology of Reproduction

      • 1st Edition
      • April 6, 2016
      • E. Diczfalusy + 1 more
      • English
      • Paperback
        9 7 8 1 4 8 3 1 1 7 8 5 0
      • eBook
        9 7 8 1 4 8 3 1 5 0 2 7 7
      Pharmacology of Reproduction is the second volume of the proceedings of the Third International Pharmacological Meeting held in Sao Paulo in 1966. The volume presents papers about the pharmacological implications of the hypothalamic control of gonadotrophin and prolactin secretion and the factors affecting hypothalamic function, with focus on the pharmacology of puberty. The luteinizing hormone (LH)-like activity in the pituitary-hypothalam... complex of children and the chemistry and physiology of follicle-stimulating hormone-releasing factor and LH-release factor are studied as well in other papers presented. The volume then tackles papers about the factors affecting the testicular function in human; immunological factors affecting spermatogenesis; and the factors stimulating the ovarian function in human. The pharmacological inhibition of the ovarian function is also considered in the volume. Practicing endocrinologists and physiologists and students taking endocrinology courses will find the book invaluable.
    • Clinical Challenges in Therapeutic Drug Monitoring

      • 1st Edition
      • May 17, 2016
      • William Clarke + 1 more
      • English
      • Paperback
        9 7 8 0 1 2 8 0 2 0 2 5 8
      • eBook
        9 7 8 0 1 2 8 0 2 0 5 2 4
      Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions and Pharmacogenomics focuses on critical issues in therapeutic drug monitoring including special requirements of therapeutic drug monitoring important to special populations (infants and children, pregnant women, elderly patients, and obese patients). The book also covers issues of free drug monitoring and common interferences in using immunoassays for therapeutic drug monitoring. This book is essential reading for any clinician, fellow, or trainee who wants to gain greater insight into the process of therapeutic drug monitoring for individual dosage adjustment and avoiding drug toxicity for certain drugs within a narrow therapeutic window. The book is written specifically for busy clinicians, fellows, and trainees who order therapeutic drug monitoring and need to get more familiar with testing methodologies, issues of interferences, and interpretation of results in certain patient populations.
    • Advances in Immunopharmacology

      • 1st Edition
      • April 19, 2016
      • J. Hadden + 2 more
      • English
      • Paperback
        9 7 8 1 4 8 3 1 1 2 9 7 8
      • eBook
        9 7 8 1 4 8 3 1 4 5 3 9 6
      Advances in Immunopharmacology documents the proceedings of the First International Conference on Immunopharmacology held in Brighton, England, in July 1980. The volume contains 60 papers organized into 10 parts. The papers in Part I examine the pharmacology of immunotherapeutic drugs and immunotoxicology. Part II presents studies on thymic hormones. Part III is devoted to immunopharmacologic approaches to diseases other than cancer. Part IV deals with mechanisms of chemotaxis degranulation and microbicidal action. Part V focuses on cancer immunopharmacology and immunotherapy while Part VI covers the mechanisms of inflammatory and allergic processes. Part VII takes up the immune testing of the actions of immunotherapeutic agents. Part VIII discusses prostaglandins and macrophage suppression. Part IX is devoted to selected topics such as mechanism of action of soluble immune response suppressor and new approaches to the therapy of allergic diseases. Part X presents discussions during the therapy communication sessions.
    • Thresholds of Genotoxic Carcinogens

      • 1st Edition
      • May 20, 2016
      • Takehiko Nohmi + 1 more
      • English
      • Hardback
        9 7 8 0 1 2 8 0 1 6 6 3 3
      • eBook
        9 7 8 0 1 2 8 0 1 8 0 3 3
      Thresholds of Genotoxic Carcinogens: From Mechanisms to Regulation brings together current opinion and research activities from Japan, the US, and Europe on the subject of genotoxic thresholds. In regulation, it is an adage that genotoxic carcinogens have no thresholds for action, and that they impose cancer risk on humans even at very low levels. This policy is frequently called into question as humans possess a number of defense mechanisms including detoxication, DNA repair, and apoptosis, meaning there is a threshold at which these genotoxic carcinogens take action. The book examines these potential thresholds, describing the potential cancer risks of daily low-level exposure, the mechanisms involved (such as DNA repair, detoxication, translesion DNA synthesis), chemical and statistical methods of analysis, and the ways in which these may be utilized to inform policy. Thresholds of Genotoxic Carcinogens: From Mechanisms to Regulation is an essential reference for any professional researchers in genetic toxicology and those involved in toxicological regulation.
    • Chelation Therapy in the Treatment of Metal Intoxication

      • 1st Edition
      • April 15, 2016
      • Jan Aaseth + 2 more
      • English
      • Hardback
        9 7 8 0 1 2 8 0 3 0 7 2 1
      • eBook
        9 7 8 0 1 2 8 0 3 0 7 3 8
      Chelation Therapy in the Treatment of Metal Intoxication presents a practical guide to the use of chelation therapy, from its basic chemistry, to available chelating antidotes, and the application of chelating agents. Several metals have long been known to be toxic to humans, and continue to pose great difficulty to treat. These challenges pose particular problems in industrial settings, with lead smelting known to be associated with hemopoietic alterations and paralyses, and the inhalation of mercury vapor in mercury mining being extremely detrimental to the central nervous system. Clinical experience has demonstrated that acute and chronic human intoxications with a range of metals can be treated efficiently by administration of chelating agents. Chelation Therapy in the Treatment of Metal Intoxication describes the chemical and biological principles of chelation in the treatment of these toxic metal compounds, including new chelators such as meso-2,3-dimercaptos... acid (DMSA) and D,L-2,3-dimercapto-1... acid (DMPS).
    • Pharmacology of Pain

      • 1st Edition
      • July 29, 2016
      • R. K. S. Lim + 2 more
      • English
      • Paperback
        9 7 8 1 4 8 3 1 2 2 8 6 1
      • Hardback
        9 7 8 0 0 8 0 0 3 2 6 7 2
      • eBook
        9 7 8 1 4 8 3 1 5 5 2 8 9
      Pharmacology of Pain, Volume 9 presents the proceedings of the 3rd International Pharmacological Meetings held in Sao Paulo in 1966. The book includes papers on the mediators of pain; proteolytic enzymes as mediators of pain; and desensitization with capsaicin and related acylamides as a tool for studying the function of pain receptors. The text also covers the sensitization of nociceptors by 5-hydroxytryptamine in man; the possible role of serotonin in affective component of pain behavioral reaction in the rat; and the use of pain induced functional impairment for assessing analgesic action. Papers on the clinical pharmacology of analgesics and analgesic antagonists; behavioral mechanisms of human pain; and central nervous mechanisms involved in pain and analgesia are also considered. The book further tackles the neuropharmacology of pain and analgesia; the interrelationship of cortical and subcortical pain systems; and the interaction of fast- and slow-conducting fiber systems involved in pain and analgesia.
    • Anticancer Treatments and Cardiotoxicity

      • 1st Edition
      • November 11, 2016
      • Patrizio Lancellotti + 2 more
      • English
      • Hardback
        9 7 8 0 1 2 8 0 2 5 0 9 3
      • eBook
        9 7 8 0 1 2 8 0 2 6 4 7 2
      Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions presents cutting edge research on the adverse cardiac effects of both radiotherapy and chemotherapy, brought together by leaders in the field. Cancer treatment-related cardiotoxicity is the leading cause of treatment-associated mortality in cancer survivors and is one of the most common post-treatment issues among survivors of adult cancer. Early detection of the patients prone to developing cardiotoxicity, taking in to account the type of treatment, history and other risk factors, is essential in the fight to decrease cardiotoxic mortality. This illustrated reference describes the most effective diagnostic and imaging tools to evaluate and predict the development of cardiac dysfunction for those patients undergoing cancer treatment. In addition, new guidelines on imaging for the screening and monitoring of these patients are also presented. Anticancer Treatments and Cardiotoxicity is an essential reference for those involved in the research and treatment of cardiovascular toxicity.